2004D-0524 - Draft Guidance for Industry: ANDAs: Pharmaceutical Solid Polymorphism; Availability
FDA Comment Number : EC2
Submitter : Dr. Nava Rotem Date & Time: 03/09/2005 04:03:05
Organization : Teva Pharmaceutical Industries Ltd.
Drug Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
See attachment